New eczema drug tested on 1000 people for itch relief and skin clearing
NCT ID NCT07276620
Summary
This study is testing an already-approved eczema medication called ivarmacitinib in a real-world setting. It will enroll 1000 adolescents and adults with moderate-to-severe atopic dermatitis to see how well it controls itching, clears skin rashes, and prevents flare-ups. The main goal is to gather more safety data and understand which patients benefit most from different treatment plans.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS (AD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.